Prudential Financial’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
Other funds holding ORMP
GIA
BCM
Prudential Financial's ORMP Position: Q3 2026 in Review
Prudential Financial opened a new position in Oramed Pharmaceuticals (ORMP) in Q3 2026: 32,440 shares worth $151K. The stake represents ﹤0.01% of the portfolio and ranks #2359 among its holdings. This is a return to the name: Prudential Financial previously reported a position in ORMP as recently as Q3 2023.
Prudential Financial first reported a position in ORMP in Q2 2023 and has held it in 3 quarters since. 93 funds tracked by Wall St. Rank hold ORMP as of Q3 2026.
- Prudential Financial held 32,440 shares of Oramed Pharmaceuticals worth $151K as of Q3 2026.
- Oramed Pharmaceuticals was a new Prudential Financial position in Q3 2026.
- Oramed Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q3 2026, its #2359 holding.
- Prudential Financial first reported a position in Oramed Pharmaceuticals in Q2 2023 and has held it in 3 quarters since.
- 93 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2026.
Based on Prudential Financial's 13F filing for Q3 2026, filed 16 Nov 2026.